Frank Onyambu

Employment

• Meru University of Science and Technology Lecturer
  2017 - Present
• Kenya Medical Research Institute Postdoctoral Trainee
  2014 - 2015
• University of Oxford Early Stage Researcher
  2009 - 2014
• Kenya Medical Research Institute Postgraduate student
  2009 - 2014

Education

• University of Oxford DPhil Clinical Lab Sciences
  2009 - 2014
• Moi University BSc Biochemistry
  2004 - 2008

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Phenotypic and genetic extended spectrum beta lactamase profiles of bacterial isolates from ICU in tertiary level hospital in Kenya
  F1000Research 2024 DOI: 10.12688/f1000research.133298.2
  +Save
• Diagnostic Accuracy of FluoroCycler® XT MTBDR Assay for Detection of Rifampicin and Isoniazid ResistantMycobacteria tuberculosisin Clinical Isolates from Kenya
  2023 DOI: 10.1101/2023.05.17.541083
  +Save
• Draft genome sequences of three emerging beta-lactamase-producing Escherichia coli in the camel production system in Northern Kenya [version 2; peer review: 2 approved]
  2023 DOI: 10.12688/f1000research.127990.2
  +Save
• Phenotypic and genetic extended spectrum beta lactamase profiles of bacterial isolates from ICU in tertiary level hospital in Kenya
  F1000Research 2023 DOI: 10.12688/f1000research.133298.1
  +Save
• Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in non-tuberculous mycobacteria isolates from Kenya [version 5; peer review: 2 approved, 1 not approved]
  2023 DOI: 10.12688/f1000research.124002.5
  +Save
• Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya
  F1000Research 2023 DOI: 10.12688/f1000research.124002.4
  +Save
• Draft genome of a clinical Pseudomonas qingdaonensis isolate from a hospitalized patient at Kenyatta National Hospital, Kenya [version 1; peer review: 2 approved]
  2022 DOI: 10.12688/f1000research.127935.1
  +Save
• Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya
  F1000Research 2022 DOI: 10.12688/f1000research.124002.3
  +Save
• Draft genome sequences of three emerging beta-lactamase-producing Escherichia coli in the camel production system in Northern Kenya
  F1000Research 2022 DOI: 10.12688/f1000research.127990.1
  +Save
• Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya
  F1000Research 2022 DOI: 10.12688/f1000research.124002.2
  +Save